Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk

(2018) Brian A Bergmark et al.   EUROPEAN HEART JOURNAL

Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

(2018) Michael Böhm et al.   EUROPEAN HEART JOURNAL

Impact of the Discordance Between the American College of Cardiology/American Heart Association and American Diabetes Association Recommendations on Hypertension in Patients With Diabetes Mellitus in the United States

(2018) Doosup Shin et al.   HYPERTENSION

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

European Society of Cardiology: Cardiovascular Disease Statistics 2017

(2017) et al.   EUROPEAN HEART JOURNAL

Effects of blood-pressure-lowering treatment on outcome incidence in hypertension

(2017) Costas Thomopoulos et al.   JOURNAL OF HYPERTENSION

Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

(2017) Michael Böhm et al.   LANCET

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results

(2017) Chenxi Huang et al.   Journal of the American Heart Association

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study

(2016) Emmanuelle Vidal-Petiot et al.   LANCET

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses

(2016) Mattias Brunström et al.   BMJ-British Medical Journal

Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses

(2016) Mattias Brunström et al.   BMJ-British Medical Journal

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

(2013) Paul A. James et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Isolated systolic hypertension

(2013) Athanase D. Protogerou et al.   JOURNAL OF HYPERTENSION

Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial

(2013)   LANCET

Diabetes and hypertension: the bad companions

(2012) Ele Ferrannini et al.   LANCET

Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose

(2011) Sripal Bangalore et al.   CIRCULATION

Blood Pressure and the Risk of Developing Diabetes in African Americans and Whites: ARIC, CARDIA, and the Framingham Heart Study

(2011) G. S. Wei et al.   DIABETES CARE

Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

(2011) Gianpaolo Reboldi et al.   JOURNAL OF HYPERTENSION

Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes

(2011) Josep Redon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

(2010) Rhonda M. Cooper-DeHoff et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE